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ABSTRACT 
Objective: To assess the efficacy of bilateral pedunculopontine nucleus deep brain stimulation 
(PPN-DBS) as a treatment for primary progressive freezing of gait (PPFG).   
Methods:  Our patient with PPFG underwent bilateral pedunculopontine nucleus deep brain 
stimulation surgery (PPN-DBS) and was followed clinically for over 14 months. 
Results: The PPFG patient exhibited a robust improvement in gait and posture following PPN-DBS. 
When PPN stimulation was deactivated postural stability and gait skills declined to pre-DBS levels 
and FDG-PET revealed hypoactive cerebellar and brainstem regions, which significantly normalised 
when PPN stimulation was reactivated.   
Conclusions: This case demonstrates that the advantages of PPN-DBS may not be limited to 
addressing freezing of gait (FOG) in idiopathic Parkinson’s disease.  The PPN may also be an 
effective DBS target to address other forms of central gait failure.   
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INTRODUCTION 
Primary progressive freezing of gait (PPFG) is a neurodegenerative disorder that causes gait 
freezing, postural instability and eventually gait akinesia. It can be associated with Parkinsonian 
features, particularly bradykinesia, but is generally unresponsive to dopaminergic medications1.  
Freezing of gait (FOG) is the key feature, which is defined as a sudden and transient motor block in 
walking motion2.  While FOG occurs in late idiopathic Parkinson’s disease (PD) it occurs commonly 
and early in the atypical Parkinsonian syndromes including progressive supranuclear palsy (PSP), 
multiple system atrophy, corticobasalganglionic degeneration, vascular Parkinsonism and post-
encephalitic Parkinsonism1.  But it can present in association with normal pressure hydrocephalus 
and orthostatic tremor1 3.   
 
The pedunculopontine nucleus (PPN) is a 5mm long, approximately sausage-shaped structure lying 
in the reticular zone at the junction of midbrain and pons4.  The PPN appear to play an important role 
in controlling axial muscle groups that mediate postural stability and gait5.  PPN-DBS of PD patients 
with FOG may improve gait5 6 though success can be variable and non-sustained7.  We hypothesised 
that since the PPN has a central role in postural stability and gait that its electrical stimulation might 
improve gait in a PPFG patient.   
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METHODS 
This 69-year-old male patient presented with an 8-year history of PPFG.  In the 12 months pre-
operatively his FOG and postural stability worsened, he fell frequently and became increasingly 
chair and bed-bound.  Pre-operative FOG questionnaire (FOG-Q) and gait and falls questionnaire 
(GF-Q) scores were 16/24 and 39/64 respectively8. 
 
Cranial MRI revealed mild generalised atrophy, slightly more prominent in the posterior fossa.  He 
was cognitively intact and exhibited mildly reduced arm swing during gait, though no other signs of 
parkinsonism or PSP9.  Clinical examination throughout the course revealed normal eye movements, 
speech and dexterity.  However, his gait was broad-based with prominent FOG and postural 
instability leading to 2 to 3 falls weekly.  His gait freezing, posture deficits and falls were 
unresponsive to L-dopa dose equivalents exceeding 1400 mg/day. 
 
DBS was performed as previously described10.  CT and 3 tesla MRI FLAIR 1.0mm contiguous axial 
slices were volumetrically fused (Stealth, Medtronic, Minneapolis, USA) and the PPN targeted on 
the MRI in stereotactic space. The PPN was located lateral to the superior cerebellar decussation at 
the level of the inferior colliculus comparing MRI images with brainstem atlases11.  A trajectory was 
chosen to approach the nucleus parallel to the axis of the brain stem and 4th ventricle and passing 
through the subthalamic region posterior to the red nuclei.  All electrodes were targeted to lie within 
the long axis of PPN with the lowest electrode in its rostral aspect. After fixation of the electrodes 
bilateral SoletraTM (Medtronic) implantable pulse generators (IPG) were placed under anaesthesia10.  
Lead position was confirmed post-operatively via 1.5T MRI. 
 
Bilateral monopolar stimulation of the IPGs was commenced 24 hours post-surgery through the most 
rostral electrode contact as these were lying within the PPN on postoperative imaging. Initial IPG 
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parameters were based on those used by Stefani et al. for “on” freezing PD patients with PPN-DBS12 
with rates of 25-30Hz and pulse widths of 60 µs.  Slightly higher stimulation rates of 35Hz were 
optimal in this patient and during the study were; right-IPG 3.5-3.8 Volts, 60µs and 35Hz and left-
IPG 2.8-3.3Volts, 60µs and 35Hz.  If PPN stimulation was withdrawn, gait function deteriorated to 
essentially his pre-operative state within 2 minutes (Table 1).  Fortunately, gait was restored within 2 
minutes of re-activating PPN-IPG stimulation.   
 
***INSERT TABLE 1 ABOUT HERE*** 
 
The patient found inactivation of his PPN stimulators very unpleasant and reporting feelings of 
unsteadiness and physical exhaustion.  Consequently, testing was conducted with frequent rest 
periods due to the patient’s significant risk of falls and injury in the IPGs-off state.   
 
Clinical assessments of gait were regularly performed pre-operatively and post-operatively in various 
on- and off-states while optimizing IPG parameters. The GF-Q and FOG-Q8, were used for pre- and 
post-operative comparison (0, 10, 20, 28, 40 and 60 weeks).   
 
Formal gait assessment and balance was undertaken 4 months pre- and 10 weeks post-operatively.  
The patient walked at a self-selected pace along a firm walkway with the PPN-DBS stimulators on or 
off for six trials each. Twenty-eight reflective markers were attached to the body in accordance with 
the Helen Hayes marker set13, which was modified to include the trunk and upper extremities.  The 
three-dimensional position of these markers was tracked (200Hz) using a six-camera motion analysis 
system (Vicon, Oxford, UK), which allowed calculation of temporospatial gait characteristics and the 
whole-body centre of mass (COM). 
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Standing balance was assessed post-operatively with PPN-IPGs on and off.  The patient stood on a 
force platform (AMTI, USA) as still as possible for 30 seconds with his eyes open (3 trials) and 
closed (3 trials).  Centre of pressure (COP) data were collected (1000Hz) and provided information 
on anteroposterior (AP) and mediolateral (ML) postural sway.   
 
F-18FDG-PET studies were performed 22 weeks after DBS surgery.  Two segmented Fluorine18 
deoxyglucose (F-18FDG) studies were performed 4 days apart with PPN-IPGs turned on and off. 
These were performed after intravenous administration of 300MBq of F-18FDG using a dedicated 
Philips Allegro PET scanner (Netherlands). For the off study, the IPGs were turned off for 30 
minutes prior to the administration of F-18FDG.  The images were reviewed using visual analysis 
and displayed in a Rainbow colour format with lower threshold of 0 and higher threshold of 8. 
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RESULTS 
GF-Q and FOG-Q scores were recorded the day before DBS surgery and again with IPGs turned on 
and off at several occasions post-operatively. Clinically the patient exhibited and reported significant 
improvement in gait stability, reduced episodes of FOG and reduced falls. These observations were 
mirrored in the improved FOG-Q and GF-Q scores when PPN stimulation was on (Table 1).   
 
PPN-DBS produced significant improvements in most gait parameters, with the exception of step 
width (Table 2).  The patient significantly increased stride length, cadence and walking velocity and 
reduced time spent in double-limb support.  Bilateral PPN-DBS also produced a significant 
improvement in mediolateral, but not anteroposterior standing balance (Table 2). This was consistent 
with the patient’s report that PPN-DBS had not improved pro- and retropulsion while walking. 
 
***INSERT TABLE 2 ABOUT HERE*** 
 
F-18FDG-PET studies with both PPN-IPG stimulators off were abnormal with a pattern of diffusely 
decreased FDG uptake compared to normal brain, which was most prominent in the brainstem and 
both cerebellar hemispheres.  With both PPN-IPGs turned on, there was a significant restoration of 
normal FDG uptake pattern in the brainstem, cerebellar and the cerebral hemispheres (Figure 1).  
This suggests that electrical stimulation of the PPN acts to return the abnormal FDG uptake pattern 
towards normal, particularly in the brainstem and cerebellum. This may explain the improved gait 
parameters, mediolateral postural sway and reduced falls. 
 
***INSERT FIGURE 1 ABOUT HERE*** 
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DISCUSSION 
Several case studies have demonstrated that DBS stimulation of the PPN can improve gait in PD 
patients with L-dopa resistant FOG5.  We reasoned that the proposed biological role for the PPN as a 
controlling element in axial posture and gait, might lead to gait improvement in patients with a PPFG 
presentation.  Our patient had progressive L-dopa resistant gait freezing and falls. Within days of 
PPN-DBS a marked improvement in gait was observed and he has had no falls since DBS surgery.  
He has required steady increases in his stimulation parameters, presumably as the underlying disease 
progresses, but has retained a stable improvement of gait now for over 14 months.  In contrast 
Ostrem et. al. recently reported a case of PPFG with PPN-DBS with only modest gait 
improvement14.  The reason for these discrepant findings may lie in the variable pathological basis 
PPFG, our case was atypical in having a history of slowly progressive gait compromise starting over 
a decade ago and no significant upper body parkinsonism to suggest PD, PSP or other parkinsonian 
syndromes.  In addition, Ostrem et al. implanted the left PPN and then right 3 months later and when 
turned off at 6 months a modest benefit was retained14.  In contrast, we implanted the PPN bilaterally 
and on each occasion the PPN stimulation was turned off the beneficial effects on gait were lost 
within minutes.  These observations imply the ongoing value of continuous PPN stimulation and the 
absence of a significant washout period or a significant lesional effect in our patient.  
 
Formal analysis showed PPN-DBS significantly improved many gait and standing balance 
parameters in our patient which were lost when stimulation was off.  The PET scan demonstrates that 
PPN stimulation increased metabolic activity of the brainstem and cerebellum.  The PPN has rich 
connection within the brainstem and with cerebellar hemispheres5 and these findings indicate that 
activation of these connections is correlated with an improvement in gait and standing stability.  
Several groups have reported that AP and ML sway are independently controlled during stance and 
visual targeting, presumably via different but interacting neuronal circuits15 16.  Our finding of 
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selective reduction of ML sway in resting stance raises the possibility that the anatomical pathways 
mediating ML sway and gait are both directly influenced by PPN activation.  Therefore, we propose 
that PPN-DBS may be a useful therapeutic modality in non-parkinsonian PPFG and possibly other 
central gait and stance disorders. 
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TABLE 1.  Freezing of gait, and gait and falls questionnaire scores pre-operatively and at 10, 20, 28, 
40 and 60 weeks after pedunculopontine nucleus deep brain stimulation. 
 Pre-op 10 weeks 20 weeks  28 weeks  40 weeks  60 weeks 
IPG 
status 
No 
IPGs 
Off On Off On Off On Off On Off On 
GF-Q 39/64 - 13/64 - 13/64 - 13/64 - 14/64  14/64 
FOG-Q 16/24 16/24 6/24 17/24 7/24 17/24 7/24 18/24 8/24 18/64 8/64 
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TABLE 2.  Formal three-dimensional gait assessment and posturography assessments with pre-
operative gait (6 trials) and post-operative gait (6 trials) and balance (3 trials) with PPN-DBS turned 
off and on. 
Gait Assessment Pre-Operative Post-Operative Significance
.  -minus 4 months  Off stimulation On stimulation 
 
Temporal Characteristics     
Cadence (steps/sec) 1.5 ± 0.0 1.4 ± 0.1 1.8 ± 0.1 a, b 
Stance Phase (% cycle) 71.1 ± 3.1 72.3 ± 2.3 66.0 ± 1.8 
a, b 
Swing Phase (% cycle) 28.9 ± 3.1 27.7 ± 2.3 34.0 ± 1.8 
Single Support (% cycle) 53.6 ± 3.4 46.8 ± 2.0 60.9 ± 1.0 
a, b 
Double Support (% cycle) 46.4 ± 3.4 53.2 ± 2.0 39.1 ± 1.0 
Walking Velocity (cm/s) 63.9 ± 6.7 47.7 ± 3.9 86.2 ± 8.3 a, b, c 
Gait Stability Ratio (steps/m) 2.4 ± 0.3 3.0 ± 0.2 2.1 ± 0.2 a, b 
     
Spatial Characteristics     
Stride Length (cm) 83.1 ± 9.7 66.2 ± 4.4 96.0 ± 7.7 a, b 
Step Width (cm) 14.3 ± 0.7 13.2 ± 2.0 13.2 ± 2.8 ns 
     
Standing Balance – Firm Surface 
(Only post-operative studies)     
Eyes Open: COP: AP - 80.9 ± 24.7 41.1 ± 7.9 ns  
COP: ML - 72.1 ± 18.3 29.4 ± 7.0 b  
COM: AP - 48.2 ± 10.1 30.1 ± 6.9 ns  
COM: ML - 49.8 ± 12.1 22.3 ± 10.7 b 
Eyes Closed: COP: AP - 61.5 ± 16.9 37.4 ± 2.3 ns  
COP: ML - 52.2 ± 12.1 33.3 ± 11.3 b  
COM: AP - 43.4 ± 15.5 26.5 ± 1.8 ns  
COM:ML - 42.5 ± 12.5 27.8 ± 12.8 b 
            ns. No significant differences between assessments (p > 0.05) 
a. Post-operative on-stimulation significantly different to pre-operative (p ≤ 0.05) 
b. Post-operative on-stimulation significantly different to post-operative off-stimulation (p ≤0.05) 
c. Pre-operative significantly different to post-operative off-stimulation (p ≤0.05) 
    
Data shown are means (±SD) and were compared using paired sample t-tests. Pre-operative studies 
and off stimulation post-operative studies were similar except for mild, but significant slowing in 
gait.  PPN-DBS on stimulation produced significant improvement in most gait parameters compared 
to both the pre-operative and off stimulation states.  In addition, mediolateral but not anteroposterior 
standing balance was also improved post-operatively by PPN-DBS stimulation. 
 
 
 
14 
 
 
FIGURE 1. F-18FDG-PET studies performed with PPN-DBS stimulation turned off (A) and on (B). 
With both PPN-IPGs stimulators turned off, there was a pattern of diffusely decreased FDG uptake 
compared to normal brain, which was most prominent in the brainstem and both cerebellar 
hemispheres.  With the PPN-IPGs turned on, there is a significant restoration of normal FDG uptake 
in the brainstem, cerebellar and probably the cerebral hemispheres.
15 
 
Authors Roles 
R Wilcox and T Coyne undertook the DBS procedure and post-operative clinical management.  R 
Wilcox and P Silburn conducted clinical assessments.  D Wong and R Wilcox undertook the PET 
study, and the PET images were reviewed by D Wong.  M Cole, G Kerr and R Wilcox undertook the 
gait and posture analysis.  All the authors contributed to the preparation of the manuscript. 
 
Financial Disclosure 
This study was self funded by the authors as an extension of the patient’s clinical management and 
not supported by specific funding.  R Wilcox, T Coyne and P Silburn received financial support from 
Medtronic Australasia to attend the Australasian deep brain stimulation meeting in 2009.  The 
authors have no financial conflicts of interest related to the research reported in this article. 
 
Acknowledgements 
None. 
 
Licence for Publication: 
The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of 
all authors, an exclusive license (or non exclusive for government employees) on a worldwide basis 
to the BMJ Publishing Group Ltd and its Licensees to permit this article (if accepted) to be published 
in the Journal of Neurology, Neurosurgery & Psychiatry editions and any other BMJPGL products to 
exploit all subsidiary rights, as set out in our license (http://jnnp .bmjjournals.com/ifora/licence.pdf). 
 
